Cohans Lifesciences and other pharmaceutical shares jump to 5% after Jefferies initiates buy recommendation

Shares of CoHance Lifesciences rose by 5.5% to RS 935 in Intraday trade after Jefferies had initiated cover with a ‘buy’ rating and a target price of RS 1.150. The global brokerage expressed a bullish look at selected Indian pharmaceutical and CRDMO companies, which assign ‘buy’ assessments to CoHance Lifesciences, Divi’s Laboratories and Sai Life […]